22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
Ryan Allway August 9th, 2022 News, Top News Strong Chicago Pilot Exceeded Expectations, Accelerates VLN® Expansion in Colorado Accretive GVB Biopharma Acquisition Doubles Corporate Revenue and Expands Market Leading Hemp/Cannabis Capabilities Second Quarter Net Sales $14.5 Million, Up 73% from the Second Quarter 2021 Strengthened Balance Sheet with $35 Million... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )